Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- FuelCell (NASDAQ: FCEL) Scrutinized Over Fit Energy Disclosures Driving Stock Down 15% - HBSSInvestors who lost money in FCEL after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
- Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSSInvestors who lost money in ALHC after its stock plunged due to potentially misleading financial statements are urged to contact Hagens Berman.
- Better Home & Finance (BETR) Faces Securities Class Action Amid 75% Sequential Increase in Net Loss, Dimmed Loan Volume ProspectsInvestors who lost money in BETR after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
- Invesco Mortgage Capital Inc.Invesco Mortgage Capital Inc. October 2026 Dividend Announcement and September Financial UpdateCompanies: InvescoInvesco Mortgage Capital Inc. (NYSE: IVR) (the "Company") today announced that the Company declared a cash dividend of $0.12 per share of common stock for the month of October 2026. The dividend will be paid on November 16, 2026 to stockholders of...
- Rocket Lab Provides Update on Neutron Development and Adjusts Target Launch TimingRocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today shared an update on the Neutron launch vehicle development program, including an adjusted schedule for Neutron’s inaugural launch, which is now expected to occur in 2027.
- The RealRealThe RealReal Announces Timing of Its Third Quarter 2026 Earnings Conference CallThe RealReal (Nasdaq: REAL)—the world's largest online marketplace for authenticated, resale luxury goods—today announced that it will release its financial results for the third quarter, ended September 30, 2026, after the market closes on...
- Mutares Portfolio Company Nord Gas Solutions Benefits From a Booming Market; 2026 Revenue Expected to Exceed EUR 575m, With Record Order Backlog of EUR 880m; Strategic Exit Options Under ReviewStrong order backlog: New orders for liquefied gas carriers, ammonia fuel supply systems, floating LNG infrastructure, biogas liquefaction and emissions recovery reflect strong demand for NGS technologies and drive total order backlog to a record high of EUR 880 million. Surging demand driven by converging industry trends, including rising global energy demand, a global focus on securing reliable energy supply and the continued focus on long-term decarbonization, energy transition and efficiency. Clear visibility on 2026 and 2027 performance: Management of NGS expects revenues of over EUR 575 million and adjusted EBITDA of approximately EUR 50 million for the full year 2026 and is confident of achieving double-digit annual revenue growth and a double-digit adjusted EBITDA margin in the full year 2027. Standalone operations and profitability: Developing strategic initiatives across the NGS’s three business areas, together with harnessing the significant growth potential in the aftermarket business serving each business area, and implementing improvements in operational efficiency, have been key priorities since the acquisition by Mutares. Strategic exit alternatives under evaluation: Mutares is evaluating potential strategic exit alternatives for NGS together with its financial advisors, including a potential public listing in the Nordics. MUNICH, GERMANY - October 14, 2026 - Mutares SE & Co. KGaA (ISIN: DE000A2NB650) (“Mutares”) announces that its portfolio company Nord Gas Solutions (“NGS”), a leading independent specialist in gas handling, fuel supply, regasification and liquefaction systems, has experienced surging demand for its gas solutions, including through new project awards, since its acquisition by Mutares. NGS was formed from the Wärtsilä Gas Solutions business and is headquartered in Asker, Norway, with around 500 employees and nine locations worldwide. NGS is a global technology leader in gas solutions, providing gas and energy technologies to international shipyards, gas producers, energy infrastructure developers and industrial customers. Its main operational centers are located in Norway, Sweden and Poland. Peter Wagner, CEO of NGS, comments: “Since becoming an independent company, we have materially grown our order backlog, which now stands at EUR 880 million. Our customers are investing in new gas infrastructure, and we are well positioned to deliver on our targets for 2026 and 2027.” The growth of NGS is underpinned by three converging megatrends. Global energy demand is rising rapidly, driven in part by the expansion of AI and data-center capacity, and is driving a new investment cycle in LNG and gas infrastructure, shipping and regasification. At the same time, heightened geopolitical tension has sharpened the focus on securing reliable and diversified energy supply, increasing demand for energy security and fast-to-deploy solutions such as floating infrastructure. Finally, the continued focus on long-term decarbonization, energy transition and efficiency is creating demand for lower-emission gas solutions. Together, these trends are driving demand for NGS technologies across the gas value chain. NGS: Strong progress in operational development In the first nine months of 2026, NGS generated revenues of approximately EUR 459 million (PY: EUR 283 million) and adjusted EBITDA[1] of EUR 43 million (PY: EUR 20 million). As of 30 September 2026, NGS holds total assets of EUR 493 million, including a very strong cash position of EUR 194 million, a reported net cash position[2] of EUR 84 million and has no financial indebtedness. Total annual revenues of NGS for the 2026 financial year are expected to exceed EUR 575 million, generating an adjusted EBITDA of approximately EUR 50 million. Since the acquisition, Mutares has worked with the management of NGS to initiate and successfully implement targeted measures to strengthen NGS’s operational performance and strategic positioning. These measures reinforce its strong market position across the gas solutions value chain and support the expansion of aftermarket and service revenues. Improved sales and project execution support commercial effectiveness and operational efficiency, driving margin development. NGS: Strong order backlog NGS’s position is reflected in its fixed order backlog, which stood at EUR 880 million as of 30 September 2026, alongside an additional pipeline of potential projects amounting to EUR 1.8 billion. NGS’s core marine business area remains a substantial part of the order book, while midstream infrastructure is growing rapidly. In marine, NGS was awarded a contract in August 2026 to supply cargo-handling and LPG fuel-supply systems for eight new liquefied gas carriers for BW LPG, each with a capacity of 90,000 m³. The vessels will be built at HD Hyundai, further strengthening the longstanding cooperation with the shipbuilding group and BW LPG. A further order, signed in June 2026, covers corresponding systems for two liquefied gas carriers for Byzantine Maritime, each with a capacity of 40,000 m³, with delivery scheduled for April 2027. For the full year 2027, the management of NGS is confident of achieving a year-on-year double-digit revenue increase alongside a double-digit adjusted EBITDA margin, given that approximately 92% of planned 2027 revenue is already covered by NGS’s fixed order backlog as of 30 September 2026. The business of NGS is also on track to achieve its mid-term targets of over EUR 800 million in annual revenue and an adjusted EBITDA of over EUR 100 million. NGS: Growth opportunities from midstream infrastructure and services business areas Midstream infrastructure is a key growth engine for NGS, led by floating storage and regasification unit (“FSRU”) projects, where project scope is increasing and customers are moving towards full conversion scope. NGS is supplying the regasification module for Excelerate Energy’s conversion of the LNG carrier “Methane Patricia Camila” into an FSRU, with delivery planned for the first half of 2028, and has received an additional order from Exmar for a regasification system for a conversion project related to the expansion of the EemsEnergyTerminal in the Netherlands. These projects reflect NGS’s established position in international LNG import infrastructure, and the use cases for its midstream technology are broadening. For the Texas GulfLink project in the United States, NGS is supplying volatile organic compound (VOC) recovery systems for two specially designed offshore support vessels, which capture emissions during crude oil loading and allow the recovered substances to be reused. In ammonia cracking, NGS and Höegh Evi have completed the first phase of performance testing of a pilot plant that converts ammonia into hydrogen, achieving a hydrogen purity of more than 99.5%. Alongside this, NGS is placing a strong focus on its high-margin services and aftermarket business, where management sees substantial potential. With an installed base of more than 1,600 systems worldwide, NGS is well placed to grow recurring revenues from field services, maintenance, spare parts, retrofits and digital services. Strategic alternatives Mutares is evaluating potential strategic exit alternatives for NGS, including a potential public listing in the Nordics in the coming months. No final decision has been made, and there can be no assurance that or at what point in time any transaction will occur. Mutares has strong confidence in NGS's prospects and, in the event of a potential public listing, expects to remain a significant shareholder, subject to customary lock-up arrangements. Company profile of Mutares SE & Co. KGaA Mutares SE & Co. KGaA, Munich (www.mutares.com),is a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Tokyo, Vienna and Warsaw, that acquires companies in transition that show significant potential for operational improvement and are resold after stabilization and repositioning. Mutares pursues a sustainable minimum dividend policy. The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol “MUX” (ISIN: DE000A2NB650) and are included in the SDAX selection index. Disclaimer This announcement does not constitute an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction. No decision has been made, and there can be no assurance that or at what point in time any transaction will occur. This announcement contains forward-looking statements based on current expectations and assumptions of the management of NGS and Mutares, which are subject to known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that may or may not occur in the future, whether or not outside the control of the relevant company. Accordingly, forward-looking statements are not guarantees of future performance and the development of the relevant company’s prospects, growth, strategies, industry and the effect of acquisitions may differ materially from those made in or suggested by the forward-looking statements contained in this announcement. In addition, even if the development of the relevant company’s prospects, growth, strategies and industry are consistent with the forward-looking statements contained in this announcement, those developments may not be indicative of the relevant company’s results, liquidity or financial position or of results or developments in subsequent periods not covered by this announcement. Forward-looking statements should therefore not be relied upon as predictions of future events. Actual results may differ materially from those expressed or implied. Neither NGS nor Mutares undertake any obligation to update forward-looking statements. For more information, please contact: Mutares SE & Co. KGaA Investor Relations Phone: +49 89 9292 7760 Email: [email protected] www.mutares.com Press Contact in Germany CROSS ALLIANCE communication GmbH Susan Hoffmeister Phone: +49 89 125 09 0333 Email: [email protected] www.crossalliance.de Press Contact in France VAE SOLIS COMMUNICATIONS Marie-Caroline Garnier Phone: +33 6 22 86 39 17 Email: [email protected] Press Contact in the UK and the US 14:46 Consulting Tom Sutton Phone: +44 7796 474940 Email: [email protected] [1] Adjusted EBITDA - Adjusted EBITDA is operating profit before depreciation, amortization and impairment, adjusted for items affecting comparability, such as carve-out, restructuring and transaction-related costs and other one-off items (including one-off bonuses). It is an alternative performance measure and is not defined by IFRS. [2] Reported net cash is defined as cash and cash equivalents, plus contract assets and receivables from group companies, less borrowings and contract liabilities.
- Compass TherapeuticsCompass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced it granted stock options to a new employee under the Company’s 2025 Inducement Plan and as a material inducement to their employment in accordance with Nasdaq Listing Rule 5635(c)(4).
- Coherus Oncology, Inc.Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026Coherus Oncology, Inc. (Nasdaq: CHRS) today announced that the Company will release interim clinical data related to its tagmokitug development program evaluating the cytolytic CCR8 antibody with toripalimab in multiple solid tumors on Wednesday, October 28, 2026. Coherus management will host a webcast from 4:30 p.m. to 6:00 p.m. Eastern Daylight Time to discuss the data and provide additional context. The company has invited key opinion leaders to join the webcast and provide their clinical perspective.
- SNDL Inc.SNDL to Report Third Quarter 2026 Financial Results on October 27, 2026SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ("SNDL") announced today that it will release its third quarter 2026 financial results for the period ended September 30, 2026, before markets open on Tuesday, October 27, 2026.
- Gerresheimer Improves Its EcoVadis Rating and is Once Again Awarded GoldGerresheimer among the top 5% of all rated companies Overall score increased to 82 out of 100 points Ranked in the top 1% in sustainable procurement DUSSELDORF, GERMANY - October 14, 2026 - Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, has once again been awarded Gold by the sustainability rating provider EcoVadis. EcoVadis evaluates the management systems of companies worldwide in the categories of environment, labor and human rights, ethics, and sustainable procurement. More than 175,000 companies are evaluated by EcoVadis each year. In the latest rating, Gerresheimer increased its score from 78 (2025) to 82 out of 100 points. This places Gerresheimer among the top 5% of all companies rated by EcoVadis and within the top 2% in its industry. With this rating result, Gerresheimer underscores its progress in consistently implementing its sustainability targets. "With the improved EcoVadis rating and our first voluntary report based on the CSRD, we are making our sustainability performance measurable and transparent for our customers," explains Wolf Lehmann, CFO of Gerresheimer AG. "We remain committed to consistently pursuing our ambitious sustainability targets in the future." Gerresheimer among the top 2% in its industry Since 2011, Gerresheimer has relied on EcoVadis to have its sustainability management independently assessed across four different dimensions. In 2022, Gerresheimer achieved Gold status for the first time with a score of 68 out of 100 points and continued to improve its overall rating in the following years. In 2026, the company once again increased its score to 82 out of 100 points, placing Gerresheimer not only among the top 5% of all companies evaluated by EcoVadis but also within the top 2% in the industry. Gerresheimer performs particularly well in the area of sustainable procurement. Here, Gerresheimer ranks among the top 1% in the industry, underscoring the importance of responsible supply chains for its own sustainability performance. Internationally recognized sustainability rating EcoVadis’ comprehensive Corporate Social Responsibility (CSR) assessment framework is based on internationally recognized standards such as the UN Global Compact, the conventions of the International Labor Organization (ILO), the standards of the Global Reporting Initiative (GRI), the ISO 26000 standard, the CERES Principles, and the UN Guiding Principles on Business and Human Rights. The EcoVadis rating thus covers a wide range of information on companies performance in the areas of the environment, labor and human rights, ethics, and sustainable procurement, while taking industry-specific characteristics into account. Ambitious sustainability targets Gerresheimer has set ambitious goals to achieve measurable progress in the areas of climate protection, the circular economy, responsible supply chains, and social responsibility. With clear performance indicators, transparent reporting, and independent assessments, Gerresheimer ensures that progress is documented comprehensively and can be compared with international benchmarks. For the 2025 financial year, Gerresheimer has, for the first time, voluntarily submitted an audited, non-financial consolidated report based on the Corporate Sustainability Reporting Directive (CSRD). In doing so, the company has significantly advanced the structure of its sustainability reporting. The report is available for download here. In addition, Gerresheimer discloses relevant data annually on the EcoVadis platform and as part of the CDP rating. MSCI, Sustainalytics, and ISS also evaluate the company’s sustainability performance. An overview of Gerresheimer’s external sustainability assessments is available here. About Gerresheimer Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of primary packaging solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes infusion, dropper and syrup bottles, tablet containers, vials, syringes, pens, auto-injectors, inhalers, ampoules, cartridges, on-body devices as well as digital solutions for therapy support. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With 39 production sites in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. The Group generated revenues of around EUR 2.3bn in 2025 and employs over 13,000 people. Gerresheimer AG is listed on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6). www.gerresheimer.com Contact Gerresheimer Media Jutta Lorberg Group Senior Director Communication & Marketing T +49 211 6181 264 [email protected] Dersim Korkmaz Manager Corporate Communication T +49 211 6181 296 [email protected] Investor Relations Guido Pickert Vice President Investor Relations T +49 211 6181 220 [email protected]
- RedCloud Holdings plcRedCloud Receives Expected Nasdaq Staff Delisting Determination and Files Appeal to Preserve Listing Pending Panel HearingAs a result of the appeal, there is no immediate impact on the listing of RedCloud ordinary shares, which continue to trade in the normal manner on the Nasdaq Capital Market under the symbol “RCT”